Seeing Is Believing
Currently out of the existing stock ratings of Joseph Thome, 18 are a BUY (62.07%), 11 are a HOLD (37.93%).
Analyst Joseph Thome, currently employed at TD COWEN, carries an average stock price target met ratio of 61.11% that have a potential upside of 36.43% achieved within 174 days. Previously, Joseph Thome worked at COWEN.
Joseph Thome’s has documented 59 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UTHR, United Therapeutics at 21-Oct-2024.
Analyst best performing recommendations are on PTCT (PTC THERAPEUTICS).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 7/20/2020. The price target of $50 was fulfilled within 1 day with a profit of $3.29 (6.17%) receiving and performance score of 61.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$200
$62.25 (45.19%)
$190
2 days ago
(20-Feb-2025)
6/34 (17.65%)
$70.9 (54.92%)
108
Buy
$153
$15.25 (11.07%)
$121
3 days ago
(19-Feb-2025)
19/21 (90.48%)
$24.91 (19.45%)
298
Buy
$153
$15.25 (11.07%)
$133
3 days ago
(19-Feb-2025)
8/9 (88.89%)
$24.91 (19.45%)
98
Buy
$176
$38.25 (27.77%)
$125
11 days ago
(11-Feb-2025)
3/4 (75%)
$43.8 (33.13%)
342
Buy
$167
$29.25 (21.23%)
$106
11 days ago
(11-Feb-2025)
6/8 (75%)
$34.8 (26.32%)
71
Which stock is Joseph Thome is most bullish on?
What Year was the first public recommendation made by Joseph Thome?